Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth M Jaffee

Showing results (21-30 of 291) with videos related to

Pageof 30
Sort By:
Cancer Immunology Research|May 6, 2014
Can we predict mutant neoepitopes in human cancers for patient-specific vaccine therapy?Eric R Lutz, Elizabeth M Jaffee
The New England Journal of Medicine|December 21, 2017
Tumor Mutational Burden and Response Rate to PD-1 InhibitionMark Yarchoan, Alexander Hopkins, Elizabeth M Jaffee
The Journal of Clinical Investigation|August 2, 2018
Emerging strategies for combination checkpoint modulators in cancer immunotherapyAleksandra Popovic, Elizabeth M Jaffee, Neeha Zaidi
Nature Reviews. Cancer|May 16, 2025
Recent advances in therapeutic cancer vaccinesNeeha Zaidi, Elizabeth M Jaffee, Mark Yarchoan
Methods in Molecular Biology (Clifton, N.J.)|January 30, 2013
Development of a cytokine-modified allogeneic whole cell pancreatic cancer vaccineDan Laheru, Barbara Biedrzycki, Elizabeth M Jaffee
Cancer Discovery|April 17, 2023
Achieving the Goals of the Cancer Moonshot Requires Progress against All CancersMonica M Bertagnolli, Danielle Carnival, Elizabeth M Jaffee
Nature Reviews. Clinical Oncology|May 14, 2020
The tumour microenvironment in pancreatic cancer - clinical challenges and opportunitiesWon Jin Ho, Elizabeth M Jaffee, Lei Zheng
The Journal of Clinical Investigation|March 15, 2022
Messenger RNA vaccines for cancer immunotherapy: progress promotes promiseAmanda L Huff, Elizabeth M Jaffee, Neeha Zaidi
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 2010
Tumor antigen-targeted, monoclonal antibody-based immunotherapy: clinical response, cellular immunity, and immunoescapeRobert L Ferris, Elizabeth M Jaffee, Soldano Ferrone
International Journal of Cancer|February 11, 2005
Tumor-specific CD4+ T cells from a patient with renal cell carcinoma recognize diverse shared antigensJosef Mautner, Elizabeth M Jaffee, Drew M Pardoll
Pageof 30

Showing results (21-30 of 291) with videos related to

Sort By:
Pageof 30
Cancer Immunology Research|May 6, 2014
Can we predict mutant neoepitopes in human cancers for patient-specific vaccine therapy?Eric R Lutz, Elizabeth M Jaffee
The New England Journal of Medicine|December 21, 2017
Tumor Mutational Burden and Response Rate to PD-1 InhibitionMark Yarchoan, Alexander Hopkins, Elizabeth M Jaffee
The Journal of Clinical Investigation|August 2, 2018
Emerging strategies for combination checkpoint modulators in cancer immunotherapyAleksandra Popovic, Elizabeth M Jaffee, Neeha Zaidi
Nature Reviews. Cancer|May 16, 2025
Recent advances in therapeutic cancer vaccinesNeeha Zaidi, Elizabeth M Jaffee, Mark Yarchoan
Methods in Molecular Biology (Clifton, N.J.)|January 30, 2013
Development of a cytokine-modified allogeneic whole cell pancreatic cancer vaccineDan Laheru, Barbara Biedrzycki, Elizabeth M Jaffee
Cancer Discovery|April 17, 2023
Achieving the Goals of the Cancer Moonshot Requires Progress against All CancersMonica M Bertagnolli, Danielle Carnival, Elizabeth M Jaffee
Nature Reviews. Clinical Oncology|May 14, 2020
The tumour microenvironment in pancreatic cancer - clinical challenges and opportunitiesWon Jin Ho, Elizabeth M Jaffee, Lei Zheng
The Journal of Clinical Investigation|March 15, 2022
Messenger RNA vaccines for cancer immunotherapy: progress promotes promiseAmanda L Huff, Elizabeth M Jaffee, Neeha Zaidi
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 2010
Tumor antigen-targeted, monoclonal antibody-based immunotherapy: clinical response, cellular immunity, and immunoescapeRobert L Ferris, Elizabeth M Jaffee, Soldano Ferrone
International Journal of Cancer|February 11, 2005
Tumor-specific CD4+ T cells from a patient with renal cell carcinoma recognize diverse shared antigensJosef Mautner, Elizabeth M Jaffee, Drew M Pardoll
Pageof 30